Artificial Neural Networks in Evaluation and Optimization of Modified Release Solid Dosage Forms
AbstractImplementation of the Quality by Design (QbD) approach in pharmaceutical development has compelled researchers in the pharmaceutical industry to employ Design of Experiments (DoE) as a statistical tool, in product development. Among all DoE techniques, response surface methodology (RSM) is the one most frequently used. Progress of computer science has had an impact on pharmaceutical development as well. Simultaneous with the implementation of statistical methods, machine learning tools took an important place in drug formulation. Twenty years ago, the first papers describing application of artificial neural networks in optimization of modified release products appeared. Since then, a lot of work has been done towards implementation of new techniques, especially Artificial Neural Networks (ANN) in modeling of production, drug release and drug stability of modified release solid dosage forms. The aim of this paper is to review artificial neural networks in evaluation and optimization of modified release solid dosage forms. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ibrić, S.; Djuriš, J.; Parojčić, J.; Djurić, Z. Artificial Neural Networks in Evaluation and Optimization of Modified Release Solid Dosage Forms. Pharmaceutics 2012, 4, 531-550.
Ibrić S, Djuriš J, Parojčić J, Djurić Z. Artificial Neural Networks in Evaluation and Optimization of Modified Release Solid Dosage Forms. Pharmaceutics. 2012; 4(4):531-550.Chicago/Turabian Style
Ibrić, Svetlana; Djuriš, Jelena; Parojčić, Jelena; Djurić, Zorica. 2012. "Artificial Neural Networks in Evaluation and Optimization of Modified Release Solid Dosage Forms." Pharmaceutics 4, no. 4: 531-550.